Zedott Baby Sachet contains Racecadotril 10 mg, an effective antidiarrheal agent indicated for the symptomatic treatment of acute diarrhea in infants and young children. Racecadotril acts as an enkephalinase inhibitor, reducing the secretion of water and electrolytes into the intestinal lumen without affecting intestinal motility, thereby helping to restore normal stool consistency and frequency. This mechanism offers a favorable safety profile by minimizing the risk of constipation or rebound constipation commonly associated with other antidiarrheal medications. Zedott Baby Sachet is formulated for easy administration in pediatric patients, ensuring accurate dosing and improved compliance. It is recommended for use alongside oral rehydration therapy to prevent dehydration and maintain electrolyte balance during diarrheal episodes. The sachet contents should be dissolved in a small volume of water before administration. Use of Zedott Baby Sachet is contraindicated in cases of hypersensitivity to Racecadotril or any excipients, and it should be avoided in patients with chronic diarrhea or underlying conditions requiring specific treatment. Adverse effects are generally mild and infrequent, with occasional reports of rash or transient rash-like symptoms. Healthcare professionals should advise caregivers on appropriate dosing and monitor clinical response to ensure optimal therapeutic outcomes.